4-(2,5-dioxopyrrolidin-1-yl)benzenesulfonyl chloride, 95.0%, 1g

3-[[2-(Methacryloyloxy)ethyl]dimethylammonio]propionate>98.0%(HPLC)1g

2-Bromohexanoic Acid>98.0%(GC)(T)25g

3-(3,5-Bis(trifluoromethyl)phenyl)propanoic acid, 97%, 1g

tert-Butyl 2-chloropyrimidine-4-carboxylate, 97.0%, 25g

3,5-Dimethyl-1-(4-nitrophenyl)piperazine, 98%, 50mg

3-Fluoro-5-nitrobenzaldehyde, 95.0%, 1g

(E)-Methyl 4-aminobut-2-enoate hydrochloride, 97%, 1g

Sodium ((2S,3R)-3-methyloxiran-2-yl)phosphonate, 95.0%, 25g

GC capillary column ROTI®Cap-1701, 15 m, 0.25 mm, 0.25 µm, 1 Piece(s)

3-(4-Chlorophenoxy)-1,2-propanediol, 99.0%, 500g

2-(4-Fluorophenyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-amine, 95.0%, 500mg

N,N-Dimethylnicotinamide-2-sulfonamide, 95.0%, 100g